EU clears use of remdesivir to fight virus

The European Commission, the bloc’s executive arm, on Friday authorised the use of anti-viral drug remdesivir to treat COVID-19. “Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus,” said EU Health Commissioner Stella Kyriakides. At least two major U.S. studies have shown that remdesivir can reduce the duration of hospital stays for COVID-19 patients.

Recommended for you